title: Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival.
abstract: By use of cDNA array technology we have screened 588 genes to determine the effect of autocrine production of human growth hormone (hGH) on gene expression in human mammary carcinoma cells. We have used a previously described cellular model to study autocrine hGH function in which the hGH gene or a translation-deficient hGH gene was stably transfected into MCF-7 cells. Fifty two of the screened genes were regulated, either positively () or negatively (), by autocrine production of hGH. We have now characterized the role of one of the up-regulated genes, chop (gadd153), in the effect of autocrine production of hGH on mammary carcinoma cell number. The effect of autocrine production of hGH on the level of CHOP mRNA was exerted at the transcriptional level as autocrine hGH increased chloramphenicol acetyltransferase production from a reporter plasmid containing a 1-kilobase pair fragment of the chop promoter. The autocrine hGH-stimulated increase in CHOP mRNA also resulted in an increase in CHOP protein. As a consequence, autocrine hGH stimulation of CHOP-mediated transcriptional activation was increased. Stable transfection of human CHOP cDNA into mammary carcinoma cells demonstrated that CHOP functioned not as a mediator of hGH-stimulated mitogenesis but rather enhanced the protection from apoptosis afforded by hGH in a p38 MAPK-dependent manner. Thus transcriptional up-regulation of chop is one mechanism by which hGH regulates mammary carcinoma cell number.
authors: Institute of Molecular and Cell Biology, 30 Medical Drive, Singapore 117609, Republic of Singapore.
authors: H C
authors: HC
authors: Mertani
authors: T
authors: T
authors: Zhu
authors: E L
authors: EL
authors: Goh
authors: K O
authors: KO
authors: Lee
authors: G
authors: G
authors: Morel
authors: P E
authors: PE
authors: Lobie
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D022762:CCAAT-Enhancer-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology*; D003001:Cloning, Molecular; D004249:DNA Damage; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D015723:Gene Library; D019382:Human Growth Hormone / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics; D011994:Recombinant Proteins / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D051742:Transcription Factor CHOP; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D014158:Transcription, Genetic; D015533:Transcriptional Activation; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D022762:CCAAT-Enhancer-Binding Proteins; C497249:DDIT3 protein, human; D009363:Neoplasm Proteins; D011994:Recombinant Proteins; D014157:Transcription Factors; D019382:Human Growth Hormone; D051742:Transcription Factor CHOP